Cancer Summit Presses Toward Treatments in Covid’s Shadow

Published June 1, 2020

The year’s biggest meeting of cancer researchers was subjected to a coronavirus overhaul this year, but even in scaled-back form it forced investors to recalibrate their expectations for some closely watched medicines.

Related Stories